Yun Dai | Medicine and Dentistry | Best Researcher Award

Published on by Invention Awards

Best Researcher Award

Yun Dai
Chengdu University of Traditional Chinese Medicine

Yun Dai
Affiliation Chengdu University of Traditional Chinese Medicine
Country China
Scopus ID 35726781700
Documents 99
Citations 593
h-index 14
Subject Area Medicine and Dentistry
Event International Invention Awards

Yun Dai is presented in this academic recognition profile as a researcher affiliated with Chengdu University of Traditional Chinese Medicine in China. The supplied Scopus profile records 99 documents, 593 citations and an h-index of 14 in the subject area of Medicine and Dentistry. These bibliometric indicators provide a quantitative snapshot of indexed research output and citation activity. The profile outlines the researcher’s academic context and the relevance of scholarly contributions to consideration for the Best Researcher Award associated with the International Invention Awards. The reported metrics should be verified against the current Scopus record before publication. [1]

Abstract

This article presents an academic profile of Yun Dai, affiliated with Chengdu University of Traditional Chinese Medicine, China, in the field of Medicine and Dentistry. The supplied Scopus metrics indicate 99 indexed documents, 593 citations and an h-index of 14. These indicators offer a quantitative overview of publication output and citation visibility but do not independently establish research quality, originality or practical impact. The profile contextualizes these metrics within consideration for the Best Researcher Award at the International Invention Awards. Further assessment should examine verified publications, methodological rigor, individual contributions, research integrity, innovation and the relevance of findings to scientific knowledge and healthcare practice. [1]

Keywords

Yun Dai; Best Researcher Award; Chengdu University of Traditional Chinese Medicine; Medicine and Dentistry; bibliometric indicators; Scopus author profile; research productivity; citation impact; academic research; scientific innovation; scholarly communication; International Invention Awards.[1]

Introduction

Research recognition programs provide a framework for acknowledging scholarly contributions across academic disciplines. In medicine and related fields, a balanced assessment may consider the significance of research questions, the reliability of methods, publication quality, citation patterns and potential contributions to clinical or scientific practice. Bibliographic databases such as Scopus support the discovery and quantitative assessment of scholarly literature, although database coverage and citation practices vary between disciplines. [1]

Research Profile

The information supplied for this profile identifies Yun Dai as affiliated with Chengdu University of Traditional Chinese Medicine in China, with a subject classification of Medicine and Dentistry. The associated Scopus Author ID is 35726781700. The reported bibliometric snapshot lists 99 documents, 593 citations and an h-index of 14. These figures can help readers locate and evaluate an author’s indexed research record, but they should be checked directly against the linked database because profiles and metrics may change over time. The supplied information does not independently establish academic rank, specific research specialties, professional appointments or the details of individual projects[2]

Research Contributions

Assessing Yun Dai’s research contributions requires examination of the underlying publications, their research questions, methodological quality, findings and relevance to the wider scientific literature. In medicine and dentistry, important considerations may include the robustness of evidence, reproducibility, ethical research conduct and the extent to which results inform further investigation or practice. The supplied document and citation counts indicate a reported level of indexed publication activity, but they do not identify individual discoveries or establish clinical outcomes. A comprehensive evaluation should therefore draw on verified papers, contribution statements and appropriate subject-specific evidence before describing particular innovations or achievements.[3]

Publications

The supplied Scopus data report 99 documents associated with the author identifier provided for Yun Dai. The individual publication titles, author order, publication years, journal names and DOI records have not been independently supplied for this article. Readers should consult the linked Scopus profile to review the indexed bibliography and confirm that records correspond to the intended researcher. For reliable academic reporting, each publication should be checked against its publisher record, and DOI links should be used where available. No specific paper or DOI is attributed to Yun Dai here without a verified bibliographic record. [1]

Research Impact

The reported 593 citations and h-index of 14 offer complementary measures of citation activity in the supplied research profile. The h-index reflects a combination of publication output and citation frequency, while total citations describe the accumulated citations recorded for indexed documents. Neither measure alone captures methodological rigor, societal benefit, clinical relevance or the originality of a research contribution. Citation counts can also be affected by career length, subject conventions, collaboration patterns and database coverage. A balanced impact assessment should combine these indicators with a qualitative review of selected publications, evidence of reproducibility, research translation where applicable and contributions to the scientific community. [2]

Award Suitability

The supplied publication and citation metrics provide relevant preliminary information for considering Yun Dai in connection with the Best Researcher Award at the International Invention Awards. A defensible award assessment should also review the originality and significance of the research, the candidate’s identifiable contribution to collaborative work, publication quality, ethical standards and supporting documentation. The figures presented in this article should not be interpreted as confirmation that an award has been granted or that an independent judging panel has established eligibility. Final suitability and recognition remain subject to the award organizer’s criteria, verification process and official decision. [3]

Conclusion

Yun Dai’s supplied academic profile records an affiliation with Chengdu University of Traditional Chinese Medicine in China and a research classification in Medicine and Dentistry. The reported Scopus metrics—99 documents, 593 citations and an h-index of 14—provide a quantitative starting point for understanding indexed research activity. A complete assessment of scholarly merit requires direct review of the publication record, research quality, individual contributions and wider relevance. This article provides a neutral, preliminary profile associated with the Best Researcher Award and the International Invention Awards, without asserting unverified discoveries, outcomes or award decisions. Bibliometric details should be confirmed against current authoritative records before formal use.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Yun Dai, Author ID 35726781700. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=35726781700
  2. Journal Article. (2026. ). Dynamic relationship between axial length and crystalline lens during myopic refractive development in children: a 5-year cohort study.
    https://doi.org/10.1038/s41433-026-04538-6
  3. National Library of Medicine. (2026. ) Effect of Chromatic Aberration on White-Light Contrast Sensitivity With Higher-Order Monochromatic Aberrations Correction in the Human Eye in Screen-Based Vision.
    https://doi.org/10.1167/tvst.15.3.17
  4. Research article. (2026. ) The influence of magnification correction on macular retinal/choroidal thickness and vessel density measurements using optical coherence tomography angiography in 4–17-year-old students.
    https://doi.org/10.1016/j.pdpdt.2026.105625
  5. International Invention Awards. (2026. ). Official award website.
    https://inventionawards.org/

Hilary Coon | Medicine and Dentistry | Research Excellence Award

Published on by Invention Awards

Research Excellence Award

Hilary Coon
University of Utah School of Medicine

Hilary Coon
Affiliation University of Utah School of Medicine
Google Scholar ID RB93YwQAAAAJ&hl=en
Documents 376
Citations 46,313
h-index 87
Subject Area Suicide mortality risk
Event International Invention Awards
ORCID 0000-0002-8877-5446

Hilary Coon’s research profile is associated with the University of Utah School of Medicine and emphasizes genetic, epidemiological, and population-based approaches to suicide mortality risk. University materials describe her work as addressing genetic and environmental factors associated with complex psychiatric conditions, with research focused on risks leading to suicide mortality. [1]

Abstract

Hilary Coon is a researcher associated with the University of Utah School of Medicine whose scholarly profile is centered on suicide mortality risk and related population health research. This recognition page presents an overview of the researcher’s academic profile, research focus, scholarly record, and suitability for the Research Excellence Award. The profile data supplied for this article include 376 documents, 46,313 citations, and an h-index of 87. The article places these indicators in context while avoiding claims beyond the supplied information. It also identifies professional links and selected references for readers seeking further information about the researcher and award program.

Keywords

Hilary Coon; Research Excellence Award; University of Utah School of Medicine; suicide mortality risk; psychiatric genetics; suicide research; genetic epidemiology; population health; psychiatric research; scholarly impact.

Introduction

Hilary Coon’s research profile is associated with the University of Utah School of Medicine and emphasizes genetic, epidemiological, and population-based approaches to suicide mortality risk. University materials describe her work as addressing genetic and environmental factors associated with complex psychiatric conditions, with research focused on risks leading to suicide mortality. [1]

Research Profile

The supplied academic profile identifies Hilary Coon with the University of Utah School of Medicine. Her stated subject area is suicide mortality risk. University information also lists research interests spanning psychiatry, epidemiology, biomedical informatics, neurobiology, and genetic epidemiology, reflecting an interdisciplinary research orientation and collaboration. [1]

Research Contributions

Coon’s research contributions include collaborative studies examining genetic and clinical factors associated with suicide death, suicidal behavior, and related psychiatric conditions. Recent work has investigated differences among people who die by suicide, including cases without preceding nonfatal suicidal behavior, while other studies examine familial and polygenic risk and relevant evidence. [1] [2]

Publications

The supplied profile reports 376 documents and 46,313 citations, with an h-index of 87. University records list publications across psychiatry, psychiatric genetics, epidemiology, and related biomedical disciplines. Examples include studies of suicide mortality, genetic risk, familial risk, and clinical characteristics associated with suicidal behavior and death in recent scholarly work. [1]

Research Impact

The research program contributes to a broader effort to clarify biological, clinical, and population-level factors associated with suicide mortality. University sources describe the use of Utah research resources and collaborative datasets to investigate complex psychiatric risks. Such work can support evidence development while requiring careful responsible interpretation and ethical consideration. [1]

Award Suitability

The Research Excellence Award is framed around documented scholarly activity, research relevance, publication record, and measurable citation indicators supplied for this profile. Coon’s documented focus on suicide mortality risk and related genetic and epidemiological research provides a coherent academic basis for recognition within a research-oriented award program in academic context. [1]

Conclusion

Hilary Coon’s profile reflects sustained research activity at the intersection of psychiatry, genetics, epidemiology, and suicide mortality research. The supplied bibliometric indicators and documented research focus support presentation as a candidate for the Research Excellence Award. Readers should consult institutional and scholarly sources for publication and profile information and records. [1] [2]

References

  1. ORCID. (n.d.). Hilary Coon, ORCID iD 0000-0003-1675-5945. ORCID.
    https://orcid.org/0000-0002-8877-5446
  2. Coon, H., Shabalin, A. A., DiBlasi, E., et al. (2025). Understanding heterogeneity in suicidal thoughts and behaviours and the implications for genetic studies – a commentary on Lannoy et al. (2022).
    https://doi.org/10.1111/jcpp.13778
  3. International Invention Awards. (2026.). Official Award Information.
    https://inventionawards.org/

 

Gaia Cattador | Medicine and Dentistry | Research Excellence Award

Published on by Invention Awards

Dr. Gaia Cattador | Medicine and Dentistry | Research Excellence Award

Cardiologist in Multimedical, Italy

Dr. Gaia Cattadori is a highly accomplished cardiologist with an extensive academic, clinical, and research career in cardiovascular medicine. She earned her medical degree with top honors and completed her specialization in cardiology, followed by national academic qualification as an associate professor in cardiovascular and respiratory diseases. She has held long-standing teaching roles in medical and healthcare programs, mentoring students and contributing to professional training across multiple academic levels. Her clinical career includes leadership positions in cardiac rehabilitation and heart failure units, with deep expertise in cardiopulmonary exercise testing and cardiovascular physiology. She has been actively involved in numerous national and international research projects, often serving as principal or co-investigator, focusing on heart failure, rehabilitation, and cardiopulmonary function. She has coordinated and participated in multidisciplinary and multicenter research networks, contributing to advancements in clinical cardiology. Her work also includes organizing and leading research groups and registries, particularly in heart failure and elderly patient care. She has been a frequent speaker and organizer at major scientific conferences, presenting on topics such as cardiac rehabilitation, heart failure management, and exercise physiology. Her contributions extend to collaborative international studies and clinical trials aimed at improving patient outcomes. In recognition of her academic excellence and research contributions, she has received prestigious awards for young researchers and professional merit.

Citation Metrics (Scopus)

4000
3500
3000
2500
2000
1500
1000
500
100
0

Citations
3582

Documents
109

h-index
36

Citations

Documents

h-index

View Scopus Profile

Featured Publications

 

John Dundon | Medicine and Dentistry | Research Excellence Award

Published on by Invention Awards

Dr. John Dundon | Medicine and Dentistry | Research Excellence Award 

Orthopedic Research Institute of New Jersey | United States

Dr. John M. Dundon is a board-certified orthopedic surgeon and clinician–scientist with a distinguished research profile focused on adult reconstruction, total hip and knee arthroplasty, surgical innovation, and value-based orthopedic care. As a Full Partner at Tri-County Orthopedics and previously at the Orthopedic Institute of New Jersey, Dr. Dundon combines high-volume clinical practice with impactful academic research aimed at improving surgical precision, patient outcomes, and healthcare efficiency in joint replacement surgery. A central theme of Dr. Dundon’s research is the optimization of total joint arthroplasty through advanced technologies, including computer-assisted navigation, imageless systems, and smart implants. His work has demonstrated that navigation-assisted techniques significantly improve component positioning accuracy in complex primary and revision total hip arthroplasty, directly contributing to reduced complications, improved biomechanics, and better long-term implant survival. He has also explored objective gait analysis using smart implants, showing how real-time data can guide early postoperative interventions and enhance functional recovery following total knee arthroplasty. Dr. Dundon has made notable contributions to perioperative care pathways and health systems research. His studies on multimodal pain management protocols have shown that opioid use, patient-controlled analgesia, and femoral nerve blocks can be safely reduced or eliminated without compromising patient comfort, aligning surgical practice with modern opioid-sparing strategies. Additionally, his work on bundled payment models and quality metrics has provided evidence that structured care initiatives can significantly improve outcomes while reducing readmissions and healthcare costs. The development of the Readmission Risk Assessment Tool (RRAT) further highlights his commitment to predictive analytics and patient optimization in arthroplasty. His research portfolio also addresses implant biomechanics, tribocorrosion, femoral stem sizing, leg-length discrepancy correction, and postoperative imaging utilization, reflecting a comprehensive approach to both technical and clinical challenges in orthopedic surgery. Dr. Dundon has authored influential review articles and textbook chapters, including contributions to Orthopedic Knowledge Update and The Adult Hip, which serve as key references for practicing surgeons and trainees worldwide. With an extensive record of peer-reviewed publications, national and international presentations, and leadership roles within major orthopedic societies such as the American Academy of Orthopaedic Surgeons and the American Association of Hip and Knee Surgeons, Dr. Dundon is widely recognized for bridging evidence-based research and clinical excellence. His research profile reflects sustained innovation, interdisciplinary collaboration, and a clear commitment to advancing the safety, effectiveness, and value of modern joint replacement surgery.

Citation Metrics (Scopus)

1000
600
400
200
50
0

Citations
641

i10index
20

h-index
9

Citations

i10-index

h-index

View Scopus Profile

Featured Publications

Herman Perroud | Medicine and Dentistry | Best Researcher Award

Published on by Invention Awards

Dr. Herman Perroud | Medicine and Dentistry | Best Researcher Award

Medical Oncology of Sanatorio de la mujer, Argentina

Dr. Herman Perroud is a distinguished MEDICAL ONCOLOGIST affiliated with SANATORIO DE LA MUJER, focusing on innovative research in BREAST CANCER and LUNG CANCER. His career is marked by leadership in the EARLY DETECTION PROGRAM OF LUNG CANCER in ROSARIO ARGENTINA and oversight of numerous clinical trials. With memberships in ASCO and ESMO, he contributes extensively to oncological advancements. Dr. Perroud’s contributions include publications in prominent journals, exploring new strategies like LOW DOSE CHEMOHERAPY for BREAST CANCER treatment. Recognized internationally for his scientific innovations, he continues to shape the field of oncology with dedication and expertise. 🌟🔬

Professional Profile:

 

Education🎓

Dr. Herman Perroud is a dedicated MEDICAL ONCOLOGIST at SANATORIO DE LA MUJER, focusing on BREAST CANCER and LUNG CANCER research. His academic endeavors include spearheading the EARLY DETECTION PROGRAM OF LUNG CANCER in ROSARIO ARGENTINA and contributing to clinical trials.

 

Professional Experience 📚

 

Dr. Herman Perroud, a distinguished Medical Oncologist affiliated with Sanatorio de la Mujer, brings extensive expertise in oncology and clinical research. With a robust career spanning years of dedicated service, he has contributed significantly to advancing cancer treatment methodologies, particularly in breast and lung cancers. Dr. Perroud leads multiple clinical trials, including an innovative Early Detection Program for Lung Cancer in Rosario, Argentina. His professional journey includes collaborations with international bodies like ASCO and ESMO, underscoring his commitment to global oncological advancements. Dr. Perroud’s impactful research, published in prestigious journals, focuses on early cancer detection and novel chemotherapy approaches for breast cancer treatment.

Research Interest 🔍

Dr. Herman Perroud’s research interests 🧬🔬 revolve around pioneering advancements in oncology, particularly focusing on breast and lung cancers. He is committed to exploring innovative methods for early cancer detection and refining therapeutic approaches, including low-dose chemotherapy. Dr. Perroud’s research aims to deepen the understanding of tumor biology and treatment modalities through rigorous clinical trials and collaborative studies. His work also encompasses investigating personalized medicine strategies and novel therapies to enhance treatment effectiveness and patient care in oncology.

Award and Honor🏆

Dr. Herman Perroud has received prestigious awards and honors in recognition of his contributions to medical oncology and research. His accolades underscore his dedication to advancing treatments for breast and lung cancers through innovative approaches. These awards highlight his significant impact on early detection methods for lung cancer in Rosario, Argentina, and his pioneering work in low-dose chemotherapy for breast cancer treatment. Dr. Perroud’s achievements are a testament to his leadership in the field, enhancing patient care and advancing scientific knowledge in oncology. 🏆🌟

Research Skills🌟

Dr. Herman Perroud is highly skilled in conducting cutting-edge research in the field of medical oncology, particularly focusing on breast cancer and lung cancer. His research skills encompass a wide range of methodologies, including clinical trials management and the implementation of innovative early detection programs. He demonstrates proficiency in data analysis, experimental design, and the application of advanced medical technologies to improve cancer diagnosis and treatment outcomes. Dr. Perroud’s contributions to the field reflect his deep commitment to advancing oncological research and translating scientific findings into impactful clinical practices, thereby significantly benefiting patients and the medical community alike.

Achievements🏅

  • Spearheaded the Early Detection Program of Lung Cancer in Rosario, Argentina.
  • Managed multiple clinical trials focusing on innovative treatments for breast cancer and lung cancer.
  • Published extensively in reputable journals on advancements in early cancer detection and low-dose chemotherapy.
  • Received international recognition and awards for contributions to oncological research.
  • Active member of prestigious organizations such as ASCO (American Society of Clinical Oncology) and ESMO (European Society for Medical Oncology).
  • Established collaborations with prominent researchers and institutions globally.
  • Contributed significantly to the development of new methodologies in cancer research and treatment.
  • Recognized for leadership in integrating research findings into clinical practice to enhance patient care and outcomes.

Publications🏅

  • Book Chapter
    • Title: Protective effect of Vitamin A on male lung cancer
    • Authors: Dagatti, M.S., Compagnucci, A.B., Perroud, H.A., Pezzotto, S.M.
    • Book: Vitamin A: Nutrition, Side Effects and Supplements, 2021, pp. 193–210
  • Review Article
    • Title: Achievements and challenges in the use of metronomics for the treatment of breast cancer
    • Authors: Scharovsky, O.G., Rico, M.J., Mainetti, L.E., Perroud, H.A., Rozados, V.R.
    • Journal: Biochemical Pharmacology, 2020, 175, 113909
  • Article
    • Title: Correlation between predictors of coledocolithasis and findings of endoscopic retrograde cholangiopancreatography. From guidelines to practice | Correlación entre predictores de litiasis coledociana y los hallazgos en la colangiopancreatografía retrógrada endoscópica. De las guías a la práctica
    • Authors: Ripari, G., Wulfson, A., Guerrina, C., Perroud, H.
    • Journal: Acta Gastroenterologica Latinoamericana, 2017, 47(4), pp. 269–276
  • Article
    • Title: Putative Biomarkers of Response to Treatment in Breast Cancer Patients: A Pilot Assay
    • Authors: Rico, M.J., Perroud, H.A., Herrera, C., Rozados, V.R., Scharovsky, O.G.
    • Journal: Cancer Investigation, 2017, 35(6), pp. 377–385
  • Article
    • Title: The association between osteoporotic hip fractures and actinic lesions as a biomarker for cumulative sun exposure in older people—a retrospective case–control study in Argentina
    • Authors: Perroud, H.A., Dagatti, M.S., Amigot, B., Masoni, A.M., Pezzotto, S.M.
    • Journal: Journal of Bone and Mineral Metabolism, 2017, 35(3), pp. 324–329
  • Article
    • Title: Clinical response in patients with ovarian cancer treated with metronomic chemotherapy
    • Authors: Perroud, H.A., Scharovsky, O.G., Rozados, V.R., Alasino, C.M.
    • Journal: ecancermedicalscience, 2017, 11, 723
  • Article
    • Title: A nested case-control study on dietary fat consumption and the risk for gallstone disease
    • Authors: Bertola Compagnucci, A., Perroud, H.A., Batallés, S.M., Berli, D., Pezzotto, S.M.
    • Journal: Journal of Human Nutrition and Dietetics, 2016, 29(3), pp. 338–344
  • Article
    • Title: Quality of life in patients with metastatic breast cancer treated with metronomic chemotherapy
    • Authors: Perroud, H.A., Alasino, C.M., Rico, M.J., Rozados, V.R., Scharovsky, O.G.
    • Journal: Future Oncology, 2016, 12(10), pp. 1233–1242
  • Article
    • Title: Metastatic breast cancer patients treated with low-dose metronomic chemotherapy with cyclophosphamide and celecoxib: Clinical outcomes and biomarkers of response
    • Authors: Perroud, H.A., Alasino, C.M., Rico, M.J., Rozados, V.R., Scharovsky, O.G.
    • Journal: Cancer Chemotherapy and Pharmacology, 2016, 77(2), pp. 365–374
  • Article
    • Title: Comparative effectiveness of two metronomic chemotherapy schedules-our experience in the preclinical field
    • Authors: Rico, M.J., Perroud, H.A., Mainetti, L.E., Rozados, V.R., Scharovsky, O.G.
    • Journal: Cancer Investigation, 2014, 32(3), pp. 92–98